openPR Logo
Press release

Achalasia Treatment Industry is Expected to Reach Huge Growth by 2031 - Bausch Health US LLC., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals (USA) Inc

08-22-2024 01:05 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Achalasia Treatment Industry is Expected to Reach Huge Growth

DataM Intelligence has published a new research report on "Achalasia Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/achalasia-treatment-market

The Achalasia Treatment market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Achalasia treatment involves managing a condition where the esophagus's lower esophageal sphincter (LES) fails to relax properly, causing difficulty in swallowing. Treatment options include pneumatic dilation, which uses a balloon to widen the esophagus; endoscopic myotomy, which involves cutting the muscle fibers of the LES to improve relaxation; and surgical interventions like Heller myotomy. Medications such as nitrates or calcium channel blockers can also help relax the LES. The goal of treatment is to alleviate symptoms, improve swallowing, and enhance the quality of life for affected individuals.

Forecast Growth Projected:

The Global Achalasia Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Achalasia Treatment Market:

Bausch Health US LLC., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals (USA) Inc., Pfizer Inc., Accordhealthcare, AdvaCare Pharma, Merz Therapeutics, Sun Pharma Industries Ltd, Accordhealthcare, Galderma and Aetna.Segment Covered in the Achalasia Treatment Market:

By Drug Type: Calcium Channel Blockers (CCBs), Nitrates, Botulinum toxin Injection, Others

By Route of Administration: Injectable, Oral

By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

Regional Analysis:

The global Achalasia Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/achalasia-treatment-market

Regional Analysis:

The global Achalasia Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Achalasia Treatment Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Achalasia Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Achalasia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/achalasia-treatment-market

Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Achalasia Treatment Industry is Expected to Reach Huge Growth by 2031 - Bausch Health US LLC., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals (USA) Inc here

News-ID: 3631344 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Legal AI Software Market to Reach USD 3.7 Billion by 2030, Driven by Automation and Efficiency Demands | DataM Intelligence
United States Legal AI Software Market to Reach USD 3.7 Billion by 2030, Driven …
The global Legal AI Software Market reached USD 0.5 billion in 2022 and is projected to reach USD 3.7 billion by 2030, growing at a CAGR of 28.7% during the forecast period 2024-2031, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, Thomson Reuters launched its next-generation AI contract review platform, reducing document analysis time by 80% for corporate legal teams. ✅ In August 2025, A coalition of top
United States AI In Renewable Energy Market to Reach USD 4.85 Billion by 2032, Driven by Grid Optimization and Predictive Maintenance | DataM Intelligence
United States AI In Renewable Energy Market to Reach USD 4.85 Billion by 2032, D …
The global AI In Renewable Energy Market reached US$ 0.85 billion in 2024 and is projected to reach US$ 4.85 billion by 2032, growing at a CAGR of 24.32% during the forecast period 2025-2032, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, The National Renewable Energy Laboratory (NREL) launched an AI platform that improved solar generation forecasts by 30%, significantly enhancing grid reliability. ✅ In August 2025,
United States AI In Energy Market Projected to Expand at 33.45% CAGR, Reaching US$ 99.48 billion by 2032 | DataM Intelligence
United States AI In Energy Market Projected to Expand at 33.45% CAGR, Reaching U …
The global AI In Energy Market reached US$ 9.89 billion in 2024 and is projected to reach US$ 99.48 billion by 2032, growing at a CAGR of 33.45% during the forecast period 2025-2032, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, Google DeepMind partnered with a major US utility to implement AI for real-time grid optimization, reducing energy losses by 15%. ✅ In
United States Allergy Immunotherapies Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Allergy Immunotherapies Market 2025 | Growth Drivers, Trends & Mar …
Market Size and Growth The "Global Allergy Immunotherapies Market" is predicted to reach at a high CAGR of 10.4% during the forecast period (2022-2029) Key Development: United States: Recent Industry Developments ✅ In September 2025, Sanofi expanded its allergy immunotherapy portfolio by acquiring Ayvakit and early-stage immunology assets for USD 9.1 billion, enhancing its position in severe allergic conditions. ✅ In June 2025, BioVaxys Technology Corp. launched a private placement to raise USD 1.2-1.6

All 5 Releases


More Releases for Achalasia

Esophageal Achalasia Market to Reach USD 720 Million by 2034
Esophageal achalasia is a rare, chronic motility disorder characterized by the inability of the lower esophageal sphincter (LES) to relax and by the absence of normal esophageal peristalsis. This condition results in difficulty swallowing (dysphagia), regurgitation, chest pain, and weight loss. Though uncommon, achalasia has significant clinical consequences, and without proper treatment it can progress to severe esophageal dilation or even esophageal cancer in some cases. Download Full PDF Sample Copy
Achalasia Treatment Market Size And Global Industry Forecast 2034
"The achalasia treatment market is valued at approximately $1.2 billion in 2024, driven by rising incidences of esophageal disorders and advancements in therapeutic techniques. The market is projected to grow significantly, reaching an estimated $2.3 billion by 2034, reflecting a robust CAGR of 6.8% during the forecast period of 2025 to 2034. " Exactitude Consultancy., Ltd. released a research report titled "Achalasia Treatment Market". This report covers the global Achalasia Treatment
Achalasia Treatment Market to Witness Growth Acceleration By 2028
Across the globe, approximately 5% of the global population is suffering from a rare disorder, which makes the treatment of rare disorders a deliberating concern. Achalasia is a rare disorder of the oesophagus that is generally characterized by the incomplete relaxation of the lower oesophageal sphincter in response to swallowing. The symptoms of achalasia include chest pain, weight loss, heartburn, regurgitation, nocturnal coughing, dysphagia and postprandial aspiration, among others. Dysphagia
Achalasia Treatment Market Expansion Projected to Gain an Uptick During 2018 to …
Across the globe, approximately 5% of the global population is suffering from a rare disorder, which makes the treatment of rare disorders a deliberating concern. Achalasia is a rare disorder of the oesophagus that is generally characterized by the incomplete relaxation of the lower oesophageal sphincter in response to swallowing. The symptoms of achalasia include chest pain, weight loss, heartburn, regurgitation, nocturnal coughing, dysphagia and postprandial aspiration, among others. Dysphagia
Achalasia Treatment Market to receive over whelming hike in Revenues by 2018 to …
Across the globe, approximately 5% of the global population is suffering from a rare disorder, which makes the treatment of rare disorders a deliberating concern. Achalasia is a rare disorder of the oesophagus that is generally characterized by the incomplete relaxation of the lower oesophageal sphincter in response to swallowing. The symptoms of achalasia include chest pain, weight loss, heartburn, regurgitation, nocturnal coughing, dysphagia and postprandial aspiration, among others. Dysphagia
Global Achalasia Treatment Market: A comprehensive study by Key Players: Achalas …
Across the globe, approximately 5% of the global population is suffering from a rare disorder, which makes the treatment of rare disorders a deliberating concern. Achalasia is a rare disorder of the oesophagus that is generally characterized by the incomplete relaxation of the lower oesophageal sphincter in response to swallowing. The symptoms of achalasia include chest pain, weight loss, heartburn, regurgitation, nocturnal coughing, dysphagia and postprandial aspiration, among others. Dysphagia